Search research articles
Contact Us
Filters
Showing results (61-70 of 107) with videos related to
Page
of 11
Sort By:
Science (New York, N.Y.)
|
June 25, 2011
Targeted genome editing across species using ZFNs and TALENs
Andrew J Wood, Te-Wen Lo, Bryan Zeitler, et al.
Journal of Biomolecular Screening
|
June 21, 2005
Isogenic human cell lines for drug discovery: regulation of target gene expression by engineered zinc-finger protein transcription factors
Pei-Qi Liu, Siyuan Tan, Matthew C Mendel, et al.
Nature Biotechnology
|
August 15, 2009
Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases
Dirk Hockemeyer, Frank Soldner, Caroline Beard, et al.
Stem Cell Reports
|
June 18, 2014
Human intestinal tissue with adult stem cell properties derived from pluripotent stem cells
Ryan Forster, Kunitoshi Chiba, Lorian Schaeffer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 6, 2017
Prostaglandin E<sub>2</sub> Increases Lentiviral Vector Transduction Efficiency of Adult Human Hematopoietic Stem and Progenitor Cells
Garrett C Heffner, Melissa Bonner, Lauryn Christiansen, et al.
Blood
|
August 23, 2015
In vivo genome editing of the albumin locus as a platform for protein replacement therapy
Rajiv Sharma, Xavier M Anguela, Yannick Doyon, et al.
Science (New York, N.Y.)
|
December 16, 2014
Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates
Judith Straimer, Nina F Gnädig, Benoit Witkowski, et al.
Developmental Cell
|
March 18, 2009
NA-Seq: a discovery tool for the analysis of chromatin structure and dynamics during differentiation
Gaetano Gargiulo, Samuel Levy, Gabriele Bucci, et al.
Nature Cell Biology
|
February 8, 2011
Rapid and efficient clathrin-mediated endocytosis revealed in genome-edited mammalian cells
Jeffrey B Doyon, Bryan Zeitler, Jackie Cheng, et al.
Molecular Therapy. Methods & Clinical Development
|
December 1, 2016
Preclinical development and qualification of ZFN-mediated CCR5 disruption in human hematopoietic stem/progenitor cells
David L DiGiusto, Paula M Cannon, Michael C Holmes, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 107) with videos related to
Sort By:
Page
of 11
Science (New York, N.Y.)
|
June 25, 2011
Targeted genome editing across species using ZFNs and TALENs
Andrew J Wood, Te-Wen Lo, Bryan Zeitler, et al.
Journal of Biomolecular Screening
|
June 21, 2005
Isogenic human cell lines for drug discovery: regulation of target gene expression by engineered zinc-finger protein transcription factors
Pei-Qi Liu, Siyuan Tan, Matthew C Mendel, et al.
Nature Biotechnology
|
August 15, 2009
Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases
Dirk Hockemeyer, Frank Soldner, Caroline Beard, et al.
Stem Cell Reports
|
June 18, 2014
Human intestinal tissue with adult stem cell properties derived from pluripotent stem cells
Ryan Forster, Kunitoshi Chiba, Lorian Schaeffer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 6, 2017
Prostaglandin E<sub>2</sub> Increases Lentiviral Vector Transduction Efficiency of Adult Human Hematopoietic Stem and Progenitor Cells
Garrett C Heffner, Melissa Bonner, Lauryn Christiansen, et al.
Blood
|
August 23, 2015
In vivo genome editing of the albumin locus as a platform for protein replacement therapy
Rajiv Sharma, Xavier M Anguela, Yannick Doyon, et al.
Science (New York, N.Y.)
|
December 16, 2014
Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates
Judith Straimer, Nina F Gnädig, Benoit Witkowski, et al.
Developmental Cell
|
March 18, 2009
NA-Seq: a discovery tool for the analysis of chromatin structure and dynamics during differentiation
Gaetano Gargiulo, Samuel Levy, Gabriele Bucci, et al.
Nature Cell Biology
|
February 8, 2011
Rapid and efficient clathrin-mediated endocytosis revealed in genome-edited mammalian cells
Jeffrey B Doyon, Bryan Zeitler, Jackie Cheng, et al.
Molecular Therapy. Methods & Clinical Development
|
December 1, 2016
Preclinical development and qualification of ZFN-mediated CCR5 disruption in human hematopoietic stem/progenitor cells
David L DiGiusto, Paula M Cannon, Michael C Holmes, et al.
Page
of 11